1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow patritumab: new trials by email Literature Review of patritumab trials Research Report on patritumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung) Patritumab, Erlotinib, Placebo - Lung Cancer, Non-small Cell Lung Cancer | Phase 3 | Terminated | Daiichi Sankyo | 145 | 2014-03-01 | 2018-01-23 |
Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Daiichi Sankyo (1)
Belgium (1) · Canada (1) · Czechia (1) · Germany (1) · Hungary (1) · Italy (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)